Loading insider details...
Beta
Latest Form 4 (Jun 28, 2024): Grant/Award of 250,000 ARDS shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 28, 2024 | Aridis Pharmaceuticals, Inc. (ARDS) | Grant/Award | 250,000 | n/a |
| Sep 19, 2023 | Aridis Pharmaceuticals, Inc. (ARDS) | Grant/Award | 20,000 | n/a |
| Jun 15, 2023 | Aridis Pharmaceuticals, Inc. (ARDS) | Exercise/Conversion | 10,000 | n/a |
| Dec 7, 2022 | Aridis Pharmaceuticals, Inc. (ARDS) | Grant/Award | 20,000 | n/a |
| Oct 5, 2021 | Aridis Pharmaceuticals, Inc. (ARDS) | Grant/Award | 30,000 | n/a |
| Sep 8, 2021 | Aridis Pharmaceuticals, Inc. (ARDS) | Purchase | 3,009 | $12.5K |
| Apr 2, 2021 | Aridis Pharmaceuticals, Inc. (ARDS) | Grant/Award | 10,000 | n/a |
| Jun 25, 2020 | Aridis Pharmaceuticals, Inc. (ARDS) | Exercise/Conversion | 80,000 | n/a |